Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $8.8000 (7.32%) ($8.3700 - $9.2800) on Mon. Jun. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.96% (three month average) | RSI | 32 | Latest Price | $8.8000(7.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -0.2% a day on average for past five trading days. | Weekly Trend | CEMI declines -11.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) BNDX(66%) VCIT(50%) PCY(49%) VCSH(48%) CEMB(46%) | Factors Impacting CEMI price | CEMI will decline at least -5.48% in a week (0% probabilities). URA(-33%) TBT(-31%) XME(-24%) VXX(-23%) PAVE(-19%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.48% (StdDev 10.96%) | Hourly BBV | 0 () | Intraday Trend | 4.4% | | | |
|
1 - 5 Day Possible Target | $-14.73(-267.39%) | Resistance Level | $10.21 | 5 Day Moving Average | $8.65(1.73%) | 10 Day Moving Average | $9.05(-2.76%) | 20 Day Moving Average | $10.21(-13.81%) | To recent high | -43.4% | To recent low | 71.9% | Market Cap | $177m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |